참고문헌
- Elgundi Z., Reslan M., Cruz E., Sifnoitis V., Kayser V., 2017, The state-of-play and future of antibody therapeutics, Advanced drug delivery review, 122 2-19. https://doi.org/10.1016/j.addr.2016.11.004
- Lu R.M., Hwang Y.C., Liu I.J., Lee C.C., Tsai H.Z., Li H.J., Wu H.C., 2020, Development of therapeutic antibodies for the treatment of diseases, Journal of biomedical science, 27 1. https://doi.org/10.1186/s12929-019-0592-z
- Urquhart L., 2018, Market watch: Top drugs and companies by sales in 2017, Nature review drug discovery, 17 232. https://doi.org/10.1038/nrd.2018.42
- Weiner G.J., 2015, Building better monoclonal antibody-based therapeutics, Nature review cancer, 15 361-370. https://doi.org/10.1038/nrc3930
- Drucker D.J., 2020, Advances in oral peptide therapeutics, Nature review drug discovery, 19 277-289. https://doi.org/10.1038/s41573-019-0053-0
- Biostem, 2016, Introduction of peptide therapeutics, http://www.biostem.kr.
- Yu B., Hwang D., Jeon H., Kim H., Lee Y., Keum H., Kim J., Lee D.Y., Kim Y., Chung J., Jon S., 2019, A hybrid platform based on a bispecific peptide-antibody complex for targeted cancer therapy, Angewandte chemie International edition, 58 2005-2010. https://doi.org/10.1002/anie.201811509
- Fosgerau K., Hoffmann T., 2015, Peptide therapeutics: current status and future directions, Drug discovery today, 20 122-128. https://doi.org/10.1016/j.drudis.2014.10.003
- Picha K., Huang C., Bugelski P., O'Neil K., 2014, Engineering peptide therapeutics using MIMETIBODY technology, Methods of molecular biology, 1088 125-145. https://doi.org/10.1007/978-1-62703-673-3_9
- Boopathy A.V., Davis M.E., 2014, Self-assembling peptide-based delivery of therapeutics for myocardial infarction, Methods of molecular biology, 1141 159-164. https://doi.org/10.1007/978-1-4939-0363-4_10
- Vadevoo S.M.P., Gurung S., Khan F., Haque M.E., Gunassekaran G.R., Chi L., Permpoon U., Lee B., 2019, Peptide-based targeted therapeutics and apoptosis imaging probes for cancer therapy, Archives of pharmacal research, 42 150-158. https://doi.org/10.1007/s12272-019-01125-0
- Gait M.J., Arzumanov A.A., McClorey G., Godfrey C., Betts C., Hammond S., Wood M.J.A., 2019, Cell-Penetrating Peptide Conjugates of Steric Blocking Oligonucleotides as Therapeutics for Neuromuscular Diseases from a Historical Perspective to Current Prospects of Treatment, Nucleic acid therapeutics, 29 1-12. https://doi.org/10.1089/nat.2018.0747
- Saarbach J., Sabale P.M., Winssinger N., 2019, Peptide nucleic acid (PNA) and its applications in chemical biology, diagnostics, and therapeutics, Current opinion in chemical biology, 52 112-124. https://doi.org/10.1016/j.cbpa.2019.06.006
- Won Y.W., Lim K.S., Kim Y.H., 2011, Intracellular organelle-targeted non-viral gene delivery systems, Journal of controled release, 152 99-109. https://doi.org/10.1016/j.jconrel.2011.01.013
- Kim H.Y., Kim S., Youn H., Chung J.K., Shin D.H., Lee K., 2011, The cell penetrating ability of the proapoptotic peptide, KLAKLAKKLAKLAK fused to the N-terminal protein transduction domain of translationally controlled tumor protein, MIIYRDLISH, Biomaterials, 32 5262-5268. https://doi.org/10.1016/j.biomaterials.2011.03.074
- Backlund, C. M., Parhamifar, L., Minter, L., Tew, G. N., Andresen, T. L., 2019, Protein Transduction Domain Mimics Facilitate Rapid Antigen Delivery into Monocytes, Molecular pharmaceutics, 16 2462-2469. https://doi.org/10.1021/acs.molpharmaceut.9b00070
- Park T.G., Jeong J.H., Kim S.W., 2006, Current status of polymeric gene delivery systems, Advanced drug delivery review, 58 467-486. https://doi.org/10.1016/j.addr.2006.03.007